Copyright Reports & Markets. All rights reserved.

Global Long-acting Polypeptide Fatty Acid Side Chain Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Long-acting Polypeptide Fatty Acid Side Chain Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Laboratory Grade
    • 1.3.3 GMP Grade
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Long-acting Polypeptide Fatty Acid Side Chain Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Liraglutide
    • 1.4.3 Semaglutide
    • 1.4.4 Telportide
    • 1.4.5 Other
  • 1.5 Global Long-acting Polypeptide Fatty Acid Side Chain Market Size & Forecast
    • 1.5.1 Global Long-acting Polypeptide Fatty Acid Side Chain Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Long-acting Polypeptide Fatty Acid Side Chain Sales Quantity (2020-2031)
    • 1.5.3 Global Long-acting Polypeptide Fatty Acid Side Chain Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Pukang Biotechnology Technology
    • 2.1.1 Pukang Biotechnology Technology Details
    • 2.1.2 Pukang Biotechnology Technology Major Business
    • 2.1.3 Pukang Biotechnology Technology Long-acting Polypeptide Fatty Acid Side Chain Product and Services
    • 2.1.4 Pukang Biotechnology Technology Long-acting Polypeptide Fatty Acid Side Chain Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Pukang Biotechnology Technology Recent Developments/Updates
  • 2.2 Changsha Morning Shine
    • 2.2.1 Changsha Morning Shine Details
    • 2.2.2 Changsha Morning Shine Major Business
    • 2.2.3 Changsha Morning Shine Long-acting Polypeptide Fatty Acid Side Chain Product and Services
    • 2.2.4 Changsha Morning Shine Long-acting Polypeptide Fatty Acid Side Chain Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Changsha Morning Shine Recent Developments/Updates
  • 2.3 SINOPEG
    • 2.3.1 SINOPEG Details
    • 2.3.2 SINOPEG Major Business
    • 2.3.3 SINOPEG Long-acting Polypeptide Fatty Acid Side Chain Product and Services
    • 2.3.4 SINOPEG Long-acting Polypeptide Fatty Acid Side Chain Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 SINOPEG Recent Developments/Updates
  • 2.4 JenKem Technology
    • 2.4.1 JenKem Technology Details
    • 2.4.2 JenKem Technology Major Business
    • 2.4.3 JenKem Technology Long-acting Polypeptide Fatty Acid Side Chain Product and Services
    • 2.4.4 JenKem Technology Long-acting Polypeptide Fatty Acid Side Chain Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 JenKem Technology Recent Developments/Updates
  • 2.5 Sichuan Tongsheng Biopharmaceutical
    • 2.5.1 Sichuan Tongsheng Biopharmaceutical Details
    • 2.5.2 Sichuan Tongsheng Biopharmaceutical Major Business
    • 2.5.3 Sichuan Tongsheng Biopharmaceutical Long-acting Polypeptide Fatty Acid Side Chain Product and Services
    • 2.5.4 Sichuan Tongsheng Biopharmaceutical Long-acting Polypeptide Fatty Acid Side Chain Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Sichuan Tongsheng Biopharmaceutical Recent Developments/Updates

3 Competitive Environment: Long-acting Polypeptide Fatty Acid Side Chain by Manufacturer

  • 3.1 Global Long-acting Polypeptide Fatty Acid Side Chain Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Long-acting Polypeptide Fatty Acid Side Chain Revenue by Manufacturer (2020-2025)
  • 3.3 Global Long-acting Polypeptide Fatty Acid Side Chain Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Long-acting Polypeptide Fatty Acid Side Chain by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Long-acting Polypeptide Fatty Acid Side Chain Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Long-acting Polypeptide Fatty Acid Side Chain Manufacturer Market Share in 2024
  • 3.5 Long-acting Polypeptide Fatty Acid Side Chain Market: Overall Company Footprint Analysis
    • 3.5.1 Long-acting Polypeptide Fatty Acid Side Chain Market: Region Footprint
    • 3.5.2 Long-acting Polypeptide Fatty Acid Side Chain Market: Company Product Type Footprint
    • 3.5.3 Long-acting Polypeptide Fatty Acid Side Chain Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Long-acting Polypeptide Fatty Acid Side Chain Market Size by Region
    • 4.1.1 Global Long-acting Polypeptide Fatty Acid Side Chain Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Long-acting Polypeptide Fatty Acid Side Chain Consumption Value by Region (2020-2031)
    • 4.1.3 Global Long-acting Polypeptide Fatty Acid Side Chain Average Price by Region (2020-2031)
  • 4.2 North America Long-acting Polypeptide Fatty Acid Side Chain Consumption Value (2020-2031)
  • 4.3 Europe Long-acting Polypeptide Fatty Acid Side Chain Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Long-acting Polypeptide Fatty Acid Side Chain Consumption Value (2020-2031)
  • 4.5 South America Long-acting Polypeptide Fatty Acid Side Chain Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Long-acting Polypeptide Fatty Acid Side Chain Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Long-acting Polypeptide Fatty Acid Side Chain Sales Quantity by Type (2020-2031)
  • 5.2 Global Long-acting Polypeptide Fatty Acid Side Chain Consumption Value by Type (2020-2031)
  • 5.3 Global Long-acting Polypeptide Fatty Acid Side Chain Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Long-acting Polypeptide Fatty Acid Side Chain Sales Quantity by Application (2020-2031)
  • 6.2 Global Long-acting Polypeptide Fatty Acid Side Chain Consumption Value by Application (2020-2031)
  • 6.3 Global Long-acting Polypeptide Fatty Acid Side Chain Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Long-acting Polypeptide Fatty Acid Side Chain Sales Quantity by Type (2020-2031)
  • 7.2 North America Long-acting Polypeptide Fatty Acid Side Chain Sales Quantity by Application (2020-2031)
  • 7.3 North America Long-acting Polypeptide Fatty Acid Side Chain Market Size by Country
    • 7.3.1 North America Long-acting Polypeptide Fatty Acid Side Chain Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Long-acting Polypeptide Fatty Acid Side Chain Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Long-acting Polypeptide Fatty Acid Side Chain Sales Quantity by Type (2020-2031)
  • 8.2 Europe Long-acting Polypeptide Fatty Acid Side Chain Sales Quantity by Application (2020-2031)
  • 8.3 Europe Long-acting Polypeptide Fatty Acid Side Chain Market Size by Country
    • 8.3.1 Europe Long-acting Polypeptide Fatty Acid Side Chain Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Long-acting Polypeptide Fatty Acid Side Chain Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Long-acting Polypeptide Fatty Acid Side Chain Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Long-acting Polypeptide Fatty Acid Side Chain Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Long-acting Polypeptide Fatty Acid Side Chain Market Size by Region
    • 9.3.1 Asia-Pacific Long-acting Polypeptide Fatty Acid Side Chain Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Long-acting Polypeptide Fatty Acid Side Chain Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Long-acting Polypeptide Fatty Acid Side Chain Sales Quantity by Type (2020-2031)
  • 10.2 South America Long-acting Polypeptide Fatty Acid Side Chain Sales Quantity by Application (2020-2031)
  • 10.3 South America Long-acting Polypeptide Fatty Acid Side Chain Market Size by Country
    • 10.3.1 South America Long-acting Polypeptide Fatty Acid Side Chain Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Long-acting Polypeptide Fatty Acid Side Chain Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Long-acting Polypeptide Fatty Acid Side Chain Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Long-acting Polypeptide Fatty Acid Side Chain Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Long-acting Polypeptide Fatty Acid Side Chain Market Size by Country
    • 11.3.1 Middle East & Africa Long-acting Polypeptide Fatty Acid Side Chain Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Long-acting Polypeptide Fatty Acid Side Chain Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Long-acting Polypeptide Fatty Acid Side Chain Market Drivers
  • 12.2 Long-acting Polypeptide Fatty Acid Side Chain Market Restraints
  • 12.3 Long-acting Polypeptide Fatty Acid Side Chain Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Long-acting Polypeptide Fatty Acid Side Chain and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Long-acting Polypeptide Fatty Acid Side Chain
  • 13.3 Long-acting Polypeptide Fatty Acid Side Chain Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Long-acting Polypeptide Fatty Acid Side Chain Typical Distributors
  • 14.3 Long-acting Polypeptide Fatty Acid Side Chain Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Long-acting Polypeptide Fatty Acid Side Chain market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Long-acting polypeptide fatty acid side chains are a technology that extends the half-life of polypeptide molecules in the body by introducing fatty acid side chains into them. By binding to polypeptides, fatty acid side chains can increase their affinity with plasma proteins (such as albumin), reduce renal clearance, and thus prolong the existence time of polypeptides in the blood. This modification technology is widely used in the development of long-acting drugs, such as polypeptide drugs for the treatment of chronic diseases such as diabetes and obesity, to reduce the frequency of medication and improve patient compliance and treatment effects.
    This report is a detailed and comprehensive analysis for global Long-acting Polypeptide Fatty Acid Side Chain market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Long-acting Polypeptide Fatty Acid Side Chain market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2020-2031
    Global Long-acting Polypeptide Fatty Acid Side Chain market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2020-2031
    Global Long-acting Polypeptide Fatty Acid Side Chain market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2020-2031
    Global Long-acting Polypeptide Fatty Acid Side Chain market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/kg), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Long-acting Polypeptide Fatty Acid Side Chain
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Long-acting Polypeptide Fatty Acid Side Chain market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pukang Biotechnology Technology, Changsha Morning Shine, SINOPEG, JenKem Technology, Sichuan Tongsheng Biopharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Long-acting Polypeptide Fatty Acid Side Chain market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Laboratory Grade
    GMP Grade
    Market segment by Application
    Liraglutide
    Semaglutide
    Telportide
    Other
    Major players covered
    Pukang Biotechnology Technology
    Changsha Morning Shine
    SINOPEG
    JenKem Technology
    Sichuan Tongsheng Biopharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Long-acting Polypeptide Fatty Acid Side Chain product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Long-acting Polypeptide Fatty Acid Side Chain, with price, sales quantity, revenue, and global market share of Long-acting Polypeptide Fatty Acid Side Chain from 2020 to 2025.
    Chapter 3, the Long-acting Polypeptide Fatty Acid Side Chain competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Long-acting Polypeptide Fatty Acid Side Chain breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Long-acting Polypeptide Fatty Acid Side Chain market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Long-acting Polypeptide Fatty Acid Side Chain.
    Chapter 14 and 15, to describe Long-acting Polypeptide Fatty Acid Side Chain sales channel, distributors, customers, research findings and conclusion.

    Buy now